Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ALGN -23.5%, MXL -22.1%, SLP -13.1%, MAT -11.1%, HAS -11%, VKTX -10.7%, EW -7.3%, BC -6.9%, MYRG -6.6%, WHR -6.1%, UCTT -5.1% (also acquires HIS Innovations Group), TSCO -5.1%, TPH -5%, SHYF -5%, BMY -4.9%, LUV -4.7%, SBSI -4.4%, AGR -4.2%, WST -4.2%, CYH -4.1%, FTAI -4%, URI -4%, OII -3.9%, ALSN -3.8%, KALU -3.8%, META -3.8%, CLS -3.5%, ENSG -3.3%, VMI -3.2%, UL -3.2%, TAK -3.1%, BG -3.1%, IEX -3% (also names new CFO), UPS -3%, LEA -2.8%, QS -2.7%, INVH -2.7%, EIG -2.6%, VLTO -2.5%, HTZ -2.5%, VMC -2.4%, GSHD -2.3%, OSTK -2.3%, SAVE -2.3%, KVUE -2.2%, IP -2.1%, LKQ -2%, WCN -1.8% (also increases dividend), CMCSA -1.8%, LSTR -1.7%, EG -1.7%, WPP -1.6%, ATR -1.4%, LC -1.4%, LH -1.4%, TER -1.1%, TER -1.1%, ROL -1%, FCFS -1%, ULCC -1%
Other news:
- ITRI -1.8% (unveils I.E.E. settlements)
- STLA -1.7% (to become a strategic shareholder of Leapmotor with €1.5 billion investment)
- CBUS -1.4% (files $200 mln mixed shelf securities offering)
- LIAN -1.2% (announces presentation of data from Phase 2a study of Infigratinib)
Analyst comments:
- ARQT -3.8% (downgraded to Neutral from Buy at Mizuho)
- FTV -2.5% (downgraded to Neutral from Buy at BofA Securities)
- BCS -2.3% (downgraded to Underperform from Neutral at BofA Securities)
- BOKF -2.3% (downgraded to Equal Weight from Overweight at Wells Fargo)
- BBWI -2.2% (downgraded to Hold from Buy at Jefferies)
- TMO -1.5% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)